This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case

Yves Merot, MD; Ellen Gravallese, MD; Francisco J. Guillén, MD; George F. Murphy, MD

Arch Dermatol. 1986;122(4):455-458.

Abstract
• Toxic epidermal necrolysis is a life-threatening disease, the pathogenesis of which remains largely unknown. Histologically, in addition to the characteristic epidermal alterations, there is a sparse mononuclear cell infiltrate in the dermis. The immunologic characteristics of this infiltrate are not well known. In a case of drug-induced toxic epidermal necrolysis with fatal outcome in a 48-year-old man, we demonstrated that the majority of the inflammatory cells were of helper/inducer T-lymphocyte subsets, having only a minority of cytotoxic/ suppressor T-lymphocytes and rare cells with natural killer cell phenotype. The significance of these observations is discussed, with reference to the occurrence of lesions at epithelial sites bearing local networks of antigen-presenting cells (Langerhans' cells).

(Arch Dermatol 1986;122:455-458)

Author Affiliations
From the Dermatopathology Laboratory, Department of Pathology, Brigham and Women's Hospital, and the Harvard Medical School, Boston. Dr Merot is a visiting research fellow from the Clinique de Dermatologie, Hôpital Cantonal Universitaire, Geneva.

Footnotes
Accepted for publication Jan 7, 1986.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal Necrolysis
Quinn et al.
Arch Dermatol 2005;141:683-687.
ABSTRACT | FULL TEXT  

Severe Adverse Cutaneous Reactions to Drugs
Roujeau and Stern
NEJM 1994;331:1272-1285.
FULL TEXT  

Macrophages and Tumor Necrosis Factor {alpha} in Toxic Epidermal Necrolysis
Paquet et al.
Arch Dermatol 1994;130:605-608.
ABSTRACT  

Impaired Antigen Presentation in Toxic Epidermal Necrolysis
Bagot et al.
Arch Dermatol 1993;129:721-727.
ABSTRACT  

Cutaneous T-Cell Recruitment in Toxic Epidermal Necrolysis: Further Evidence of CD8+ Lymphocyte Involvement
Correia et al.
Arch Dermatol 1993;129:466-468.
ABSTRACT  

Immunopathology of Toxic Epidermal Necrolysis: Keratinocytes, HLA-DR Expression, Langerhans Cells, and Mononuclear Cells: An Immunopathologic Study of Five Cases
Villada et al.
Arch Dermatol 1992;128:50-53.
ABSTRACT  

T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis: Possible Pathogenic Mechanism Induced by CD8-Positive T Cells
Miyauchi et al.
Arch Dermatol 1991;127:851-855.
ABSTRACT  

Toxic Epidermal Necrolysis: Unmuddying the Waters
Goldstein et al.
Arch Dermatol 1987;123:1153-1156.
ABSTRACT